Related Experiment Video
Updated: Jul 16, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition
Frank Gillardon1, Wolfgang Rist1, Lothar Kussmaul1
1Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Abstract:
Synaptic dysfunction is an early event in Alzheimer's disease patients and has also been detected in transgenic mouse models. In the present study, we analyzed proteomic changes in synaptosomal fractions from Tg2576 mice that overexpress mutant human amyloid precursor protein (K670N, M671L) and from their nontransgenic littermates. Cortical and hippocampal tissue was microdissected at the onset of cognitive impairment, but before deposition of amyloid plaques. Crude synaptosomal fractions were prepared by differential centrifugation, proteins were separated by 2-D DIGE and identified by MS/MS. Significant alterations were detected in mitochondrial heat shock protein 70 pointing to a mitochondrial stress response. Subsequently, synaptosomal versus nonsynaptic mitochondria were purified from Tg2576 mice brains by density gradient centrifugation. Mitochondrial proteins were separated by IEF or Blue-native gel electrophoresis in the first dimension and SDS-PAGE in the second dimension. Numerous changes in the protein subunit composition of the respiratory chain complexes I and III were identified. Levels of corresponding mRNAs remain unchanged as shown by Affymetrix oligonucleotide array analysis. Functional examination revealed impaired state 3 respiration and uncoupled respiration in brain mitochondria from young Tg2576 mice. By immunoblotting, amyloid-beta oligomers were detected in synaptosomal fractions from Tg2576 mice and reduced glucose metabolism was observed in Tg2576 mice brains by [14C]-2-deoxyglucose infusion. Taken together, we demonstrate alterations in the mitochondrial proteome and function that occur in Tg2576 mice brains before amyloid plaque deposition suggesting that mitochondria are early targets of amyloid-beta aggregates.
Insights
Mitochondrial dysfunction and stress occur early in Alzheimer's disease models, before amyloid plaques form. These changes in brain mitochondria suggest they are an initial target of amyloid-beta aggregates.
Area of Science:
- Neuroscience
- Biochemistry
- Mitochondrial Biology
Background:
- Synaptic dysfunction is an early Alzheimer's disease (AD) hallmark.
- Transgenic mouse models of AD exhibit synaptic deficits.
- Investigating early molecular changes is crucial for understanding AD pathogenesis.
Purpose of the Study:
- To analyze proteomic alterations in synaptosomes from Tg2576 mice before amyloid plaque deposition.
- To identify early mitochondrial changes in the context of Alzheimer's disease.
- To correlate proteomic findings with mitochondrial function and glucose metabolism.
Main Methods:
- Proteomic analysis (2-D DIGE, MS/MS) of synaptosomal fractions from Tg2576 and wild-type mice.
- Purification and proteomic analysis (2-D electrophoresis, SDS-PAGE) of brain mitochondria.
- Assessment of mitochondrial respiration and mRNA levels (oligonucleotide array).
- Detection of amyloid-beta oligomers and measurement of brain glucose metabolism.
Main Results:
- Significant alterations in mitochondrial heat shock protein 70 indicated mitochondrial stress.
- Changes in respiratory chain complexes I and III subunits were identified.
- Impaired mitochondrial respiration (state 3 and uncoupled) was observed in young Tg2576 mice.
- Amyloid-beta oligomers were detected, and glucose metabolism was reduced prior to plaque formation.
Conclusions:
- Mitochondrial proteome and function are altered early in Tg2576 mouse brains.
- These mitochondrial changes precede amyloid plaque deposition.
- Mitochondria represent early targets of amyloid-beta aggregates in Alzheimer's disease pathogenesis.
More Related Videos
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

